Rap1-suppressed tumorigenesis is concomitant with the interference in Ras effector signaling

Yea Lih Lin*, Clément Mettling, Chen Kung Chou

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

6 Scopus citations

Abstract

Expression of Rap1 blocks epithelial growth factor-induced extracellular signal-regulated kinases (ERKs) activation. However, recent studies demonstrated that Rap1 mediates ERKs activation induced by nerve growth factor. The anti-oncogenic effect of Rap1 has been reported but its mechanism remains unclear. To evaluate the correlation between the anti-transforming effect and the activation of ERKs, we transfected rap1 cDNA into Hep3B cells and selected stable transfectants. The Rap1 transfectants completely lost their intrinsic tumorigenicity in Balb/c nude mice. Both insulin and 12-O-tetradecanoyl phorbol-13-acetate (TPA)-stimulated ERK activations were also blocked. Our findings suggest that Rap1-suppressed tumorigenicity is concomitant with ERKs inhibition. Copyright (C) 2000 Federation of European Biochemical Societies.

Original languageEnglish
Pages (from-to)184-188
Number of pages5
JournalFEBS Letters
Volume467
Issue number2-3
DOIs
StatePublished - 11 02 2000
Externally publishedYes

Keywords

  • 12-O-Tetradecanoyl phorbol-13-acetate
  • Extracellular signal-regulated kinase
  • GTPase
  • Insulin
  • Mitogenesis
  • Rap1

Fingerprint

Dive into the research topics of 'Rap1-suppressed tumorigenesis is concomitant with the interference in Ras effector signaling'. Together they form a unique fingerprint.

Cite this